News


Lia Mae Pellegrini joins as Product Development Engineering Intern

We are excited to welcome Lia Mae Pellegrini as a Product Development Engineering Intern! Lia Mae holds a First Class Honours Master’s in Product Design Engineering from Queen’s University Belfast, where in her final year of university she reached the finals of both the Co-Founders programme run by the Northern Ireland tech hub Catalyst and …

UHCW NHS Trust News

Trust leads clinical trial of pioneering product to tackle threatened miscarriage 8 April 2025 Experts from University Hospitals Coventry and Warwickshire (UHCW) NHS Trust are to lead a clinical trial of a novel device aimed at addressing threatened miscarriage. More than 150,000 women a year in the UK could be helped by Callavid® which is designed …

CLCC at Microbes in Women’s Health Congress – Amsterdam

Our colleague Elham Shirani  will be at the second Microbes in Women’s Health Congress in Amsterdam on 9-10 April. 🇳🇱 We’re excited to meet with existing and new partners for 2 days of talks, panels and networking.  Our user convenient Callavid® drug delivery platform will help provide effective colonisation and epithelial adherence of live biotherapeutics …

NIHR news: New trial to test device treating threatened miscarriage

[From NIHR: National Institute for Health and Care Research] We have awarded £1 million in funding to a first of its kind technology that’s being trialled to address threatened miscarriage. Currently, over 150,000 women in the UK experience threatened miscarriage a year. If approved, the device would become the world’s first drug-device combination to treat …

Raising funding for Tommy’s Charity 🏃‍♀️

🎉 Congratulations to our colleague Sabrina Franco for completing the London Landmarks Half Marathon in support of Tommy’s – the pregnancy and baby charity! We’re proud to support Sabrina’s great work and efforts in raising awareness and funds for such an important cause. 💙

CLCC awarded £1m NIHR funding to address threatened miscarriage

Pioneering technology to address threatened miscarriage secures £1 million funding and moves towards clinical trials • Scientists developing a pioneering device designed to address threatened miscarriage have secured £1 million in NIHR funding to begin clinical trials • Designed to deliver vital doses of progesterone, the Callavid® device stands to help over 150,000 women each …

Miscarriage Prevention: What Science Can Do And Why It’s Not Your Fault
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

Miscarriage. You can find lots of definitions, from the rather cold  “spontaneous or unplanned expulsion of a fetus from the womb before it is able to survive independently,”  to the softer “sudden loss of a pregnancy before the 20th week.” Either way, it sucks. If you have had one, I’m sorry. So why do women …

Int’l Women’s Day
Thang Vo-Ta
Co-Founder & CEO

A slightly belated nod to International Women’s Day (as we’ve just taken this 📸 )— but still just in time for Women’s History Month. I want to take a moment to share how incredibly grateful I am to work alongside such a brilliant, dedicated, and inspiring group of women at Calla Lily Clinical Care 🔬 It’s …

Lara Joins Springboard Women’s Health Accelerator 2025 Cohort

Our co-founder Lara Zibners MD MMEd MBA has been selected to join the Springboard Enterprises 2025 Women’s Health Cohort! Lara joins a cohort featuring 12 companies that are driving innovation in areas that differently, predominantly, or solely impact women. Over the next 3 months, the selected entrepreneurs will participate in an intensive accelerator program, working …

FemHealth Integrates Conference 25 in Manchester
Serena de Gelidi, PhD
R&D Manager

☀️ The sun was shining on Manchester (apparently an unusual phenomenon) yesterday for the very first Fem Health Integrates conference. So many bright minds reunited to discuss the gaps and missed opportunities in women’s health, but mostly the future steps to change the story. 🚺 Thank you to Anastassia Bolotkova for showing me around, Jessica …

당사는 웹사이트 경험을 향상시키기 위해 쿠키를 사용합니다. 당사는 웹사이트 기능이 올바로 구현되도록 만들고 보안을 유지하기 위해서 필요한 쿠키를 사용합니다. 이러한 쿠키를 항상 사용하도록 설정해야 합니다. “쿠키 수락”을 클릭하면 웹사이트 탐색을 개선하고 웹사이트 이용을 분석하고 마케팅 노력을 지원할 수 있도록 기기에 쿠키를 저장하는 것에 동의하게 됩니다. 자세한 내용은 개인 정보 보안 정책을 참조하십시오.